Description
BAY-1251152 is an inhibitor of PTEFb/CDK9. PTEFb contributes to the regulation of gene transcription and can be over-expressed in cancer cells, leading to the transcription of key tumor-promoting genes and proliferation.
| Product Unit Size | Cost | Quantity | Stock |
|---|
BAY-1251152 is an inhibitor of PTEFb/CDK9. PTEFb contributes to the regulation of gene transcription and can be over-expressed in cancer cells, leading to the transcription of key tumor-promoting genes and proliferation.
| Cas No. | 1610358-56-9 |
|---|---|
| Purity | ≥98% |
| Formula | C19H18F2N4O2S |
| Formula Wt. | 404.44 |
| IUPAC Name | 5-Fluoro-4-(4-fluoro-2-methoxyphenyl)-N-{4-[(S-methylsulfonimidoyl)methyl]-2-pyridinyl}-2-pyridinamine |
| Synonym | BAY 1251152, BAY1251152 |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Luecking U., Scholz A., et al. Identification of potent and highly selective PTEFb inhibitor BAY 1251152 for the treatment of cancer: from p.o. to i.v. application via scaffold hops. Cancer Res. 77(13 Suppl):Abstract nr 984 (2017).
Naphthalene; indirect STAT1 agonist.
Selective CDK2 inhibitor.
Tetrapeptide, IgG Fc region derivative; Nrp1 ag...
Major metabolite of ginsenosides Rb1, Rb2, Rc, ...
PRMT5/MTA complex inhibitor
B-Raf, VEGFR2, c-Raf, PDGFR, CSF-1R, RET, c-Kit...
Cdc7 inhibitor.
Coumarin, more potent isomer; VKORC1 inhibitor....
Fatty acid metabolite of chlorophyll; RXR and P...
Synthetic quinone CoQ analog, promotes mitochon...
Fast skeletal muscle troponin complex activator...
Benzimidazole; microtubule polymerization inhib...
Benzimidazole; microtubule polymerization inhib...
PKA inhibitor, potential ROCK, S6K1, MSK1, PKB ...
γ-Secretase inhibitor.
BHA derivative.
Natriuretic, vasodilatory peptide; B1/2 agonist...
Inhibitor of Akt.
Endogenous peptide, cleavage product of angiote...
Peptide, substance P analog; NK agonist.